(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ivermectin: Oral tablet (3mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_10023.JPG
Stromectol 3mg Tab
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: MSD  |  32

What is this Medicine?

IVERMECTIN (eye ver MEK tin) is an anti-infective. It is used to treat infections of some parasites.

Similar Brand Name Drugs : Stromectol: Oral tablet (3mg)
In-Depth Information

Ivermectin 3mg Tablet

NDC: 427990806
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Onchocerciasis, Strongyloidiasis

Sometimes used for but not FDA approved for the following conditions:
Cutaneous Larva Migrans, Filariasis, Pediculosis, Crusted (Norwegian) Scabies, Scabies

Storage Information
Store below 86 degrees F
Ivermectin 3mg Tablet

Reported Side Effects for Ivermectin 3mg Tablet

Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Within The Eye Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Tiredness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fecal Incontinence Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Brain Dysfunction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Uncontrolled Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Coma Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
0.9%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
0.9%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
0.9%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Tired Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Hives Incidence:
0.9-22.7%*
Severity: MILD
Onset: RAPID
Balance Problems Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Postural Low Blood Pressure Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
1.2%*
Severity: SEVERE
Onset: RAPID
Upset Stomach Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
2.8-27.5%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
2.8%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
3.0-13.9%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
3.2%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
3.5%*
Severity: MODERATE
Onset: RAPID
Joint Pain Incidence:
9.3%*
Severity: MILD
Onset: DELAYED
Joint Inflammation Incidence:
9.3%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
22.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ivermectin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5